ArticleAlzheimer's research & therapy2024

CSF neurogranin levels as a biomarker in Alzheimer's disease and frontotemporal lobar degeneration: a cross-sectional analysis.

Vanesa Jurasova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.